百倍の酵素特異性のために無機ナノ酵素に分子インプリント
Zijie Zhang1, Xiaohan Zhang1, Biwu Liu1
1Department of Chemistry, Waterloo Institute for Nanotechnology, University of Waterloo , Waterloo, Ontario N2L 3G1, Canada.
Journal of the American Chemical Society
|March 28, 2017
まとめ
研究者はナノ材料にポリマーを育てることで特定のナノ酵素を開発し,酵素のような活動を強化しました. この分子インプリント技術により バイオセンサや環境浄化などの用途の 特殊性が向上します
科学分野:
- 材料科学
- ナノテクノロジー
- 生物化学
背景:
- タンパク質酵素は 高い特異性を持ちますが 費用がかかり 脆弱です
- ナノ酵素 (酵素を模倣する活動を持つナノ材料) は費用対効果が高く,頑丈ですが,特異性は欠けている.
- 分子インプリントは 合成認識サイトを作るための技術です
研究 の 目的:
- 分子インプリントを用いてナノ酵素の特異性を高める.
- ナノ酵素表面に基板特有の結合ポケットを作成します.
- 異なるナノ酵素プラットフォームでのインプリント方法の汎用性を実証する.
主な方法:
- ペロキシダゼのような活性を持つFe3O4ナノ酵素に分子インプリントされたポリマーを成長させた.
- 電子顕微鏡を使って ナノゲル殻の形成を確認した
- 選択的基板結合を検証するために,同熱定位カロミテリーを使用します.
- 金のナノ粒子とナノセリアにインプリントの方法を適用した.
主要な成果:
- 中性モノマーで適度な特異性,充電されたモノマーで100倍近い特異性を達成した.
- カロリメトリーによる選択的基板結合が実証された.
- 様々なナノ酵素型 (Fe3O4,金ナノ粒子,ナノセリア) にインプリント技術を成功裏に適用した.
結論:
- 分子インプリントはナノ酵素の特異性を大幅に高めます
- ハイブリッドインプリントナノ酵素は 機能的な酵素模倣能力を向上させています
- これらの材料はバイオセンサ,分離,環境修復,薬剤投与に 期待されています
関連する概念動画
Induced-fit Model
90.8K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
90.8K
Enzymes
96.2K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
96.2K
Introduction to Mechanisms of Enzyme Catalysis
11.1K
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
11.1K
Imprinting
11.3K
Behavioral imprinting is observed in some newborn animals and occurs when they develop strong and specific attachments to another animal (usually a parent) following brief, early-life exposures. Offspring imprint onto parents within a brief period after birth or hatching; this time window is called the critical period. Once imprinting occurs, the bond established between the parents and their offspring is usually long-lasting.
11.3K
Ribozymes
13.6K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.6K
Enzyme Inhibition
94.2K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
94.2K


